Target Name: RRP1
NCBI ID: G8568
Review Report on RRP1 Target / Biomarker Content of Review Report on RRP1 Target / Biomarker
RRP1
Other Name(s): ribosomal RNA processing 1 | novel nuclear protein 1 | Protein NNP-1 | RRP1-like protein | Ribosomal RNA processing 1 homolog A | protein NNP-1 | ribosomal RNA processing 1 homolog | NOP52 | Nnp1 homolog, nucleolar protein | nucleolar protein Nop52 | RRP1A | Nucleolar protein Nop52 | Ribosomal RNA processing 1 | Novel nuclear protein 1 | OTTHUMP00000109463 | NNP-1 | Ribosomal RNA processing protein 1 homolog A | D21S2056E | RRP1_HUMAN

RRP1: A Protein Linked To Cancer and Neurodegenerative Diseases

Ribosomal RNA (RNA) processing 1 (RRP1) is a protein that plays a crucial role in the process of translation of RNA into proteins. Mutations in the RRP1 gene have been linked to a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders. As a result, RRP1 has become a promising drug target and a biomarker for a variety of diseases.

The RRP1 gene is located on chromosome 18q21 and encodes a protein that is composed of 196 amino acids. The protein has a molecular weight of 21 kDa and a pre-folding activity of 13.3 kDa. RRP1 is primarily localized to the endoplasmic reticulum (ER) and is involved in the processing of ribosomal RNA (RNA) into pre-fractured RNA.

RRP1 functions as the protein subunit of the 28S ribosome, which is the most abundant type of ribosome found in the cell. The 28S ribosome is responsible for producing the majority of proteins in the cell, including those involved in cell signaling, transport, and structure.

Mutations in the RRP1 gene have been linked to a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders. For example, studies have shown that individuals with certain genetic mutations, such as those found in the RRP1 gene, are at increased risk for developing neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

In addition to its role in the production of proteins, RRP1 is also involved in the regulation of gene expression. Studies have shown that RRP1 can interact with the protein coding gene (NCOR) and can alter the levels of gene expression in certain cells. This suggests that RRP1 may be a potential drug target for diseases that are characterized by abnormal levels of gene expression.

RRP1 has also been shown to play a role in the regulation of cellular processes that are important for the development and maintenance of tissues. For example, studies have shown that RRP1 is involved in the regulation of cell adhesion, a process that is critical for the development and maintenance of tissues such as tissues, organs, and organs.

In addition to its role in the regulation of cell adhesion and the production of proteins, RRP1 is also involved in the regulation of gene expression and in the regulation of cellular processes that are important for the development and maintenance of tissues. These functions make RRP1 a potential drug target and a biomarker for a variety of diseases.

In conclusion, RRP1 is a protein that plays a crucial role in the process of translation of RNA into proteins. Mutations in the RRP1 gene have been linked to a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders. As a result, RRP1 has become a promising drug target and a biomarker for a variety of diseases. Further research is needed to fully understand the functions of RRP1 and its potential as a drug.

Protein Name: Ribosomal RNA Processing 1

Functions: Plays a critical role in the generation of 28S rRNA

The "RRP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RRP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

RRP12 | RRP15 | RRP1B | RRP36 | RRP7A | RRP7BP | RRP8 | RRP9 | RRS1 | RRS1-DT | RS1 | RSAD1 | RSAD2 | RSBN1 | RSBN1L | RSC1A1 | RSF1 | RSKR | RSL1D1 | RSL1D1-DT | RSL24D1 | RSPH1 | RSPH10B | RSPH14 | RSPH3 | RSPH4A | RSPH6A | RSPH9 | RSPO1 | RSPO2 | RSPO3 | RSPO4 | RSPRY1 | RSRC1 | RSRC2 | RSRP1 | RSU1 | RSU1P2 | RTBDN | RTCA | RTCB | RTEL1 | RTEL1-TNFRSF6B | RTF1 | RTF2 | RTKN | RTKN2 | RTL1 | RTL10 | RTL3 | RTL4 | RTL5 | RTL6 | RTL8A | RTL8B | RTL8C | RTL9 | RTN1 | RTN2 | RTN3 | RTN4 | RTN4IP1 | RTN4R | RTN4RL1 | RTN4RL2 | RTP1 | RTP2 | RTP3 | RTP4 | RTP5 | RTRAF | RTTN | RUBCN | RUBCNL | RUFY1 | RUFY2 | RUFY3 | RUFY4 | RUNDC1 | RUNDC3A | RUNDC3A-AS1 | RUNDC3B | RUNX1 | RUNX1-IT1 | RUNX1T1 | RUNX2 | RUNX2-AS1 | RUNX3 | RUNX3-AS1 | RUSC1 | RUSC1-AS1 | RUSC2 | RUSF1 | RUVBL1 | RUVBL1-AS1 | RUVBL2 | RWDD1 | RWDD2A | RWDD2B | RWDD3